NCT05052307 - A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in Brazil | Biotech Hunter

Enrollment

4,574

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

June 20, 2022

Study Completion Date

July 20, 2023

Conditions

Covid19

Interventions

DRUG

Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine

DRUG

CoronaVac COVID-19 vaccine

DRUG

ChAdOx1 nCoV-19 Covid-19 Vaccine

DRUG

Ad26.COV2.S COVID-19 Vaccine

Trial Locations (3)

Pronto Atendimento Municipal de Toledo, Toledo

Unidade Básica de Saúde Jardim Cosmos, Toledo

Unidade de Pronto Atendimento Pediátrico Dr. José Ivo Alves da Rocha, Toledo